Zhang L - Search Results

1

The use of low molecular weight protamine to enhance oral absorption of exenatide.

Zhang L, Shi Y, Song Y, Sun X, Zhang X, Sun K, Li Y. Zhang L, et al. Among authors: zhang x. Int J Pharm. 2018 Aug 25;547(1-2):265-273. doi: 10.1016/j.ijpharm.2018.05.055. Epub 2018 May 23. Int J Pharm. 2018. PMID: 29800739

2

Tf ligand-receptor-mediated exenatide-Zn²⁺ complex oral-delivery system for penetration enhancement of exenatide.

Zhang L, Shi Y, Song Y, Duan D, Zhang X, Sun K, Li Y. Zhang L, et al. Among authors: zhang x. J Drug Target. 2018 Dec;26(10):931-940. doi: 10.1080/1061186X.2018.1455839. Epub 2018 Apr 16. J Drug Target. 2018. PMID: 29619854

3

Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.

Song Y, Shi Y, Zhang L, Hu H, Zhang C, Yin M, Chu L, Yan X, Zhao M, Zhang X, Mu H, Sun K. Song Y, et al. Among authors: zhang l, zhang c, zhang x. Mol Pharm. 2019 Feb 4;16(2):518-532. doi: 10.1021/acs.molpharmaceut.8b00809. Epub 2019 Jan 14. Mol Pharm. 2019. PMID: 30601014

4

Oral delivery system for low molecular weight protamine-dextran-poly(lactic-co-glycolic acid) carrying exenatide to overcome the mucus barrier and improve intestinal targeting efficiency.

Song Y, Shi Y, Zhang L, Hu H, Zhang C, Yin M, Zhang X, Sun K. Song Y, et al. Among authors: zhang l, zhang c, zhang x. Nanomedicine (Lond). 2019 Apr;14(8):989-1009. doi: 10.2217/nnm-2018-0322. Nanomedicine (Lond). 2019. PMID: 31088322 Free article.

5

Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice.

Shi Y, Sun X, Zhang L, Sun K, Li K, Li Y, Zhang Q. Shi Y, et al. Among authors: zhang l, zhang q. Sci Rep. 2018 Jan 15;8(1):726. doi: 10.1038/s41598-018-19170-y. Sci Rep. 2018. PMID: 29335533 Free PMC article.

6

Trastuzumab- and Fab' fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo.

Duan D, Wang A, Ni L, Zhang L, Yan X, Jiang Y, Mu H, Wu Z, Sun K, Li Y. Duan D, et al. Among authors: zhang l. Int J Nanomedicine. 2018 Mar 22;13:1831-1840. doi: 10.2147/IJN.S153795. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29606874 Free PMC article.

7

Understanding the translocation mechanism of PLGA nanoparticles across round window membrane into the inner ear: a guideline for inner ear drug delivery based on nanomedicine.

Zhang L, Xu Y, Cao W, Xie S, Wen L, Chen G. Zhang L, et al. Int J Nanomedicine. 2018 Jan 22;13:479-492. doi: 10.2147/IJN.S154968. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29403277 Free PMC article.

8

Iron-Chelated Polydopamine Decorated Doxorubicin-Loaded Nanodevices for Reactive Oxygen Species Enhanced Cancer Combination Therapy.

Li XJ, Li WT, Li ZH, Zhang LP, Gai CC, Zhang WF, Ding DJ. Li XJ, et al. Front Pharmacol. 2019 Feb 6;10:75. doi: 10.3389/fphar.2019.00075. eCollection 2019. Front Pharmacol. 2019. PMID: 30787876 Free PMC article.

9

Symbiosis theory-directed green synthesis of silver nanoparticles and their application in infected wound healing.

Wen L, Zeng P, Zhang L, Huang W, Wang H, Chen G. Wen L, et al. Among authors: zhang l. Int J Nanomedicine. 2016 Jun 10;11:2757-67. doi: 10.2147/IJN.S106662. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27358563 Free PMC article.

10

A novel strategy for the protective effect of ginsenoside Rg1 against ovarian reserve decline by the PINK1 pathway.

Yang P, Fan M, Chen Y, Yang D, Zhai L, Fu B, Zhang L, Wang Y, Ma R, Sun L. Yang P, et al. Among authors: zhang l. Pharm Biol. 2025 Dec;63(1):68-81. doi: 10.1080/13880209.2025.2453699. Epub 2025 Jan 25. Pharm Biol. 2025. PMID: 39862058

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135,375 results

Search Page

Filters